Results 31 to 40 of about 373,900 (338)

COVID-19: benefits and risks of passive immunotherapeutics

open access: yesHuman Vaccines & Immunotherapeutics, 2020
Passive immunotherapeutics (PITs), including convalescent plasma, serum, or hyperimmune immunoglobulin, have been of clinical importance during sudden outbreaks since the early twentieth century for the treatment of viral diseases such as severe acute ...
Ankur Gupta   +5 more
doaj   +1 more source

Prediction of Intrinsic Disorder in MERS-CoV/HCoV-EMC Supports a High Oral-Fecal Transmission [PDF]

open access: yes, 2013
A novel coronavirus, MERS-CoV (NCoV, HCoV-EMC/2012), originating from the Middle-East, has been discovered. Incoming data reveal that the virus is highly virulent to humans.
Dunker, A. Keith   +2 more
core   +1 more source

Digesting the crisis: autophagy and coronaviruses

open access: yesMicrobial Cell, 2020
Autophagy is a catabolic pathway with multifaceted roles in cellular homeostasis. This process is also involved in the antiviral response at multiple levels, including the direct elimination of intruding viruses (virophagy), the presentation of viral ...
Didac Carmona-Gutierrez   +6 more
doaj   +1 more source

Molecular Characterization and Amino Acid Homology of Nucleocapsid (N) Protein in SARS-CoV-1, SARSCoV-2, MERS-CoV, and Bat Coronavirus

open access: yesJournal of Pure and Applied Microbiology, 2020
Coronavirus disease – 2019 (COVID-19) pandemic, due to severe acute respiratory syndrome– coronavirus-2 (SARS-CoV-2), is posing a severe bio threat to the entire world.
Shantani Kannan   +3 more
doaj   +1 more source

Drawing parallels between SARS, MERS, and COVID-19: A comparative overview of epidemiology, pathogenesis, and pathological features

open access: yesIndian Journal of Community Medicine, 2023
Background: Since November 2019, when the novel coronavirus arose in Wuhan City, over 188 million people worldwide have been infected with COVID-19. It is the third coronavirus outbreak in the twenty-first century.
Manas Pustake   +8 more
doaj   +1 more source

Update on therapeutic options for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) [PDF]

open access: yes, 2016
This article is made available for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source.
Al-Tawfiq, Jaffar A., Memish, Ziad A.
core   +1 more source

Coronaviruses: SARS, MERS and COVID-19

open access: yesKorean Journal of Clinical Laboratory Science, 2020
Coronaviruses were originally discovered as enzootic infections that limited to their natural animal hosts, but some strains have since crossed the animal-human species barrier and progressed to establish zoonotic diseases.
Eun-Joong Kim, Dongsup Lee
doaj   +1 more source

Molecular aspects of MERS-CoV [PDF]

open access: yes, 2017
This article is made available for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source.
Al-Ahmed, Shamsah H.   +3 more
core   +1 more source

Spaced seeds improve k-mer-based metagenomic classification [PDF]

open access: yes, 2015
Metagenomics is a powerful approach to study genetic content of environmental samples that has been strongly promoted by NGS technologies. To cope with massive data involved in modern metagenomic projects, recent tools [4, 39] rely on the analysis of k ...
Brinda, Karel   +2 more
core   +2 more sources

COMPARISON between COVID-19 and MERS demographic data in Saudi Arabia: a retrospective study

open access: yesLibyan Journal of Medicine, 2021
The outbreak of corona virus disease (COVID-19) caused by the new severe acute respiratory syndrome corona virus 2 began in Wuhan, China, resulting in respiratory disorders.
Rania Ali El Hadi Mohamed   +1 more
doaj   +1 more source

Home - About - Disclaimer - Privacy